CDC20-IN-2
CDC20-IN-2 (14c), a Cdc20 inhibitor (KD: 7.65 μM), causes G2/M phase arrest and promotes DNA damage accumulation. CDC20-IN-2 (14c) stabilizes key substrates such as Cyclin B1 and Bim, leading to enhanced apoptosis and suppression of tumor cell proliferation and migration[1].
Product Specifications
CAS Number
3080812-16-1
UNSPSC
12352005
Target
APC; Apoptosis
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
FC(F)(F)C1=CC=C(NC2=CC(Cl)=NC(NC(NC(OCCNC(C3=CN=C(C(F)(F)F)S3)=O)=O)C(Cl)(Cl)Cl)=N2)C=C1
Molecular Formula
C21H15Cl4F6N7O3S
Molecular Weight
701.26
References & Citations
[1]Xiangyang Le, et al. Design, synthesis and optimization of Apcin analogues as Cdc20 inhibitors for triple-negative breast cancer therapy. Eur J Med Chem. 2025 May 5:289:117434.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS144165 100 µg
Prickle (PRICKLE1) (NM_153026) Human Over-expression Lysate
Sign In for Pricing
View Details 
A01530-2-PE 100 µg/Vial
Anti-ROBO1 Antibody Picoband®, PE Conjugate
Sign In for Pricing
View Details MBS1152905-01 0.02 mg (E-Coli)
Recombinant Acidovorax ebreus DNA-directed RNA polymerase subunit alpha (rpoA)
Sign In for Pricing
View Details MBS1152905-02 0.02 mg (Yeast)
Recombinant Acidovorax ebreus DNA-directed RNA polymerase subunit alpha (rpoA)
Sign In for Pricing
View Details MBS1152905-03 0.1 mg (E-Coli)
Recombinant Acidovorax ebreus DNA-directed RNA polymerase subunit alpha (rpoA)
Sign In for Pricing
View Details